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Ca2-dependent fusion of transport vesicles at their
target can be enhanced by intracellular Ca2 and dia-
cylglycerol. Diacylglycerol induces translocation of the
vesicle priming factor Munc13 and association of the
secretory vesicle protein DOC2B to the membrane. Here
we demonstrate that a rise in intracellular Ca2 is suf-
ficient for a Munc13-independent recruitment of DOC2B
to the target membrane. This novel mechanism occurred
readily in the absence of Munc13 and was not influenced
by DOC2B mutations that abolish Munc13 binding. Pu-
rified DOC2B (expressed as a bacterial fusion protein)
bound phospholipids in a Ca2-dependent way, suggest-
ing that the translocation is the result of a C2 domain
activation mechanism. Ca2-induced translocation was
also observed in cultured neurons expressing DOC2B-
enhanced green fluorescent protein. In this case, how-
ever, various degrees of membrane association occurred
under resting conditions, suggesting that physiological
Ca2 concentrations modulate DOC2B localization. De-
polarization of the neurons induced a complete translo-
cation of DOC2B-enhanced green fluorescent protein to
the target membrane within 5 s. We hypothesize that
this novel Ca2-induced activity of DOC2B functions
synergistically with diacylglycerol-induced Munc13
binding to enhance exocytosis during episodes of high
secretory activity.
Ca2-induced exocytosis is a widely conserved mechanism of
importance for a broad range of secretory systems, such as the
release of neurotransmitters and neuropeptides in the central
and peripheral nervous system. To attain fusion competence,
secretory vesicles must first dock at the target membrane and
undergo a process called priming. The release of fusion-ready
vesicles is coupled to the opening of Ca2 channels in the
plasma membrane, producing a transient high Ca2 concentra-
tion (10–100 M for 1 ms) in close proximity to the channels.
The inward Ca2 current then diffuses into the cytoplasm,
resulting in a residual concentration in the range of 1 M
during tens of seconds. It is widely accepted that this residual
Ca2 concentration induces short term changes in exocytotic
strength (e.g. see Refs. 1 and 2), although the mechanisms that
contribute to this phenomenon remain largely unclear. As a
result, the secretory strength of neuronal and endocrine release
sites is modulated in an activity-dependent way. This phenom-
enon is important to avoid vesicle depletion during repetitive
stimulation and is furthermore considered in neurons to con-
tribute to memory and learning.
Although Ca2 is the most important messenger after high
frequency activation of the release site, exocytotic potentiation
can also be induced by diacylglycerol (synthesized by members
of the phospholipase family) or by its phorbolester analogues.
Diacylglycerol has multiple intracellular targets (e.g. protein
kinase C isoforms), but the potentiating effect in regulated
exocytosis is mediated by the priming factor Munc13-1.
Munc13-1-deficient mice die shortly after birth and show a
defect in synaptic vesicle exocytosis from glutamatergic syn-
apses, presumably due to an arrest between the docking and
fusion steps of the synaptic vesicle cycle (3). In another study,
the Munc13-1 gene was replaced with the allele Munc13-
1H567K, encoding a mutant protein that specifically lacks dia-
cylglycerol-binding activity. Hippocampal neurons from ho-
mozygous Munc13-1H567K mice show normal evoked
postsynaptic currents (4). However, the readily releasable pool
size is diminished, the recovery from high frequency stimula-
tion is slowed down, and the potentiating effect of phorbolest-
ers is blocked (4). Thus, Munc13-1 may enhance vesicle prim-
ing during high frequency stimulation through acting as a
diacylglycerol sensor. Several studies have suggested that the
potentiating activity of Munc13 involves its interaction with
proteins of the DOC2 family, as discussed below.
The DOC2 protein family comprises three isoforms, desig-
nated DOC2A, -B, and -C. The latter is predominantly ex-
pressed in the heart (5). DOC2A and DOC2B are both ex-
pressed in the brain, and in addition DOC2B is found in several
peripheral tissues (6, 7). In subcellular fractionations, DOC2A
and -B copurify with secretory vesicles, although they lack a
transmembrane domain. DOC2 proteins consist of three struc-
tural domains: a short N-terminal domain and two C2 domains
named C2A and C2B, respectively, similar to those in synap-
totagmins and protein kinase C (PKC).1 This presence of these
motifs predicts a Ca2-binding function. For DOC2B, this was
experimentally confirmed in vitro; Ca2 induced binding of the
isolated C2A domain to phosphatidylserine-containing lipo-
somes with half-maximal binding at 1 M Ca2 (8). A positive
function in secretion was suggested by the increased release of
growth hormone from PC12 cells overexpressing DOC2A (9).
Both DOC2A and -B bind Munc13-1 in a diacylglycerol-de-
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pendent manner (10). This interaction is mediated by the
Munc13-interacting domain located within the N-terminal do-
main of DOC2. Interestingly, diacylglycerol also induces a
Munc13-1-dependent translocation of DOC2B to the plasma
membrane in HEK293 cells (11). Injection of a synthetic pep-
tide identical to the Munc13-interacting domain region into
cholinergic neurons of the superior cervical ganglion was
shown to inhibit synaptic transmission in an activity-depend-
ent manner (12). Similarly, injection of this peptide into the
Calyx of Held blocked the potentiating effect of phorbolester
administered 5 min after the peptide (13). Together, these data
suggest that the DOC2-Munc13 interaction contributes to the
mechanism of diacylglycerol-induced presynaptic potentiation.
DOC2 proteins also bind to Munc18, a syntaxin-binding pro-
tein that is required for neurotransmitter secretion (7, 14). In
chromaffin cells of the adrenal gland, homozygous Munc18 null
mice showed a 10-fold reduction in morphologically docked
vesicles and a corresponding reduction in Ca2-dependent exo-
cytosis of large dense core vesicles (15). Many overexpression
studies with Munc18 homologs have been reported with seem-
ingly conflicting results, in general supporting the hypothesis
that Munc18 exerts its function in the final stages upstream
from Ca2-induced vesicle exocytosis at least in mammalian
systems (16).
Here we describe a novel mechanism for the translocation of
DOC2B to the membrane, triggered by intracellular Ca2. In
contrast to the diacylglycerol-induced translocation, Ca2-de-
pendent translocation occurs independent of Munc13 binding.
Since diacylglycerol and Ca2 activation generally coincide
during episodes of high secretory activity, we hypothesize that
both mechanisms may act in concert to increase the exocytotic
strength.
EXPERIMENTAL PROCEDURES
Antibodies—A polyclonal antibody designated 13.2 was raised
against DOC2B by immunizing New Zealand White rabbits with 500 g
of a bacterially expressed polypeptide comprising amino acids 22–116 of
DOC2B. The serum recognized a single protein of the expected molec-
ular mass as determined by Western blotting using rat brain homoge-
nate. It also reacted strongly with lysate from HEK293 cells expressing
fusion proteins consisting of DOC2B and enhanced green fluorescent
protein (EGFP) but not EGFP alone. The mouse monoclonal anti-Myc
tag antibody 9E10 and the mouse monoclonal anti-EGFP antibody B34
were purchased from Babco (Richmond, CA).
Construction of Expression Vectors—A cDNA fragment encoding full-
length wild type DOC2B (GenBankTM accession number U70778) was
amplified by polymerase chain reaction with the DNA polymerase PfuI
(Stratagene, La Jolla, CA) using the rat cDNA clone pNP3a as template
(7). The sense primer (5-ttggtacccgctgacttaccccc-3) introduces a KpnI
restriction site 69 nucleotides upstream of the start codon; the anti-
sense primer (5-gcggatcccgtcgtcgagtacagc-3) removes the stop codon
and introduces a BamHI restriction site. This fragment was introduced
into pEGFP-N2 (Clontech) using the corresponding sites. Expression
vectors encoding Myc-tagged DOC2B were derived from this vector by
subcloning the NheI-BamHI fragment into the corresponding sites of
pCDNA3.1-Myc-HisC (Invitrogen). Expression vectors encoding
Munc13-1, PKC-, and PKC- were described previously (17–19).
Site-directed Mutagenesis—Complementary DNAs encoding the mu-
tant fusion proteins listed in Table I were generated by site-directed
mutagenesis, performed by full-length amplification of the pEGFP-N2-
DOC2B expression vector with mutagenic primers. PfuI DNA polymer-
ase (Roche Applied Science) was used for amplification. Template DNA
was selectively degraded by incubation with DpnI endonuclease, and
the PCR product was introduced into Escherichia coli DH5. The in-
tegrity of all mutant cDNAs was confirmed by sequence analysis of the
complete open reading frame on a Beckman CEQ 2000 automated
sequencer (Fullerton, CA). All DOC2B variants (wild type and mutant)
were also subcloned into pCDNA3.1 and pCDNA3.1-Myc (Invitrogen).
Cell Culture—HEK293 (ATCC CRL 1573) were cultured at 37 °C in
the presence of 5% (v/v) CO2 in Dulbecco’s modified Eagle’s medium
containing sodium pyruvate, pyridoxine, and 1 g/liter glucose (Invitro-
gen) supplemented with 10% heat-inactivated fetal calf serum (Invitro-
gen), 1 mM glutamine, 1 nonessential amino acids (Gibco), 200 IU/ml
penicillin, and 200 g/ml streptomycin. One day after seeding on glass
coverslips in 6-well plates, the cells were transfected with 2.5 g of
vector DNA using the standard calcium phosphate precipitation
method. For co-expression of Munc13-1, the expression vector
pCDNA3-Munc13-1 was added in a 3-fold molar excess over pEGFP-
DOC2B. Medium was refreshed at 16 and 40 h, and translocation
assays were performed at 48–50 h post-transfection. PC12 cells were
cultured on 18-mm glass coverslips in Dulbecco’s modified Eagle’s me-
dium containing 10% horse serum, 5% fetal calf serum, 4 mM L-gluta-
mine, 100 IU/ml penicillin, and 100 g/ml streptomycin in the presence
of 5% CO2. Cells were transfected with 2 g of vector DNA using
LipofectAMINE 2000 (Invitrogen), and measurements (by total internal
reflection fluorescence microscopy) were conducted 6–8 h post-trans-
fection. Neurons were isolated from C57BL/6 mouse embryos at day 18
of gestation and seeded at 25,000 cells/cm2 in 12-well plates on poly-L-
lysine-coated coverslips in neurobasal medium (Invitrogen) supple-
mented with B-27 supplement (Invitrogen). The cells were cultured at
37 °C in a humidified chamber gassed with 5% CO2. Six h after seeding,
the neurons were transduced with lentiviral particles using a multiplic-
ity of infection of 1.5–2 infective particles/cell.
Western Blotting—Fourty-eight h post-transfection, HEK293 cells
were lysed in 10 mM Tris-HCl, pH 7.4, 1 mM EDTA, and 1% Triton
X-100. The lysate was cleared by centrifugation for 30 min at 16,000 
g, followed by electrophoresis on a 6–15% Tris-glycine gradient gel.
Proteins were transferred to a polyvinylidine difluoride membrane (Bio-
Rad). Membranes were incubated for 16 h at 4 °C in 5% blocking agent
(Amersham Biosciences) dissolved in TBST (20 mM Tris, 137 mM NaCl,
and 0.1% Tween 20), washed, and incubated with anti-GFP (Covance
Research Products, Denver, PA; diluted 1:25,000) or anti-Doc2B (13.2;
diluted 1:1,000) for 90 min in TBST. The membranes where washed
again and incubated for 1 h with alkaline phosphatase-conjugated goat
anti-mouse or goat anti-rabbit secondary antibody (Amersham Bio-
sciences) diluted 1:5,000 in TBST. Finally, the membranes were
washed, incubated for 5 min in enhanced chemifluorescence substrate
(Amersham Biosciences), and analyzed on a FLA5000 fluoroimager
(Raytest, Tilburg, The Netherlands). All incubations were carried out at
room temperature unless otherwise stated.
Immunofluorescence Microscopy—Cells were fixed 48 h post-trans-
fection for 15 min in 2% paraformaldehyde (Merck) in PBS and 15 min
in 4% paraformaldehyde. Subsequently, they were incubated in PBS
containing 4% fetal calf serum (Invitrogen) for 20 min. Next, the cells
were incubated with anti-Doc2B antibody 13.2, diluted 1:4,000 in PBS
containing 0.1% Triton X-100. As the secondary antibody we used
Alexa546-conjugated goat anti rabbit (Molecular Probes, Inc.) diluted
1:1,000 in PBS containing 0.1% Triton X-100. The cells were mounted in
Dabco-Mowiol (Sigma) and analyzed on an LSM 510 confocal micro-
scope (Carl Zeiss BV, Weesp, The Netherlands).
Confocal Imaging of Live and Fixed Cells—For imaging of EGFP
fluorescence in fixed cells, the cells were incubated for 10 min at 37 °C
in basal buffer (25 mM HEPES, pH 7.4, 140 mM NaCl, 4.7 mM KCl, 1.4
mM MgCl2, and 10 mM glucose), in ionophore-containing medium (basal
buffer supplemented with 3 mM CaCl2 and 1 M A23187) or in a
depolarizing medium containing 25 mM HEPES, pH 7.4, 90 mM NaCl,
60 mM KCl, 3 mM CaCl2, 1.4 mM MgCl2, and 10 mM glucose. A23187 was
purchased from Sigma. In case cells were fixed, this was achieved by
adding an equal volume of 4% (w/v) paraformaldehyde to the medium
and incubating for 20 min at room temperature. Neurons were then
counterstained for microtubule-associated protein 2 (MAP2; a neuron-
specific protein located in dendrites) as follows. After fixation, the cells
were washed twice with PBS and then incubated for 1 h with a mono-
clonal antibody recognizing MAP2 (Chemicon; diluted 1:200 in PBS
with 0.1% Triton X-100), washed again twice, and incubated in the
presence of Alexa546-conjugated goat anti-mouse antibodies (Molecular
Probes; diluted 1:000). Confocal imaging was performed with an LSM
TABLE I
Names of mutant DOC2B molecules generated by
site-directed mutagenesis
For each mutant, the introduced mutation and its effect on DOC2B
function are described. Numbers indicate amino acids. For both mu-
tants, the described effect is proven experimentally (12, 20).
Name Mutation Effect
TCT 2–9 Blocks Tctex-1 binding
M13 Substitution of amino
acids 15–20 (QEHMAI
to YKDWAF)
Blocks Munc13 binding
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510 confocal microscope and a 63 Plan-Neofluar lens (Carl Zeiss).
Fluorescence intensity in regions of interest was quantitated using
Multianalyst image analysis software (Bio-Rad). To test statistically if
the fluorescence intensity after stimulation was significantly different
from that before stimulation, the fluorescence after stimulation was
calculated as a percentage of the original value. This was done for each
cellular compartment in nine different cells. A two-tailed Student’s t
test was used to test whether the resulting mean values differed sig-
nificantly from 100% (p  0.005).
Total Internal Reflection Fluorescence Microscopy—Transfected
PC12 cells were incubated in basal solution containing 10 mM HEPES,
pH 7.35, 147 mM NaCl, 2.8 mM KCl, 5 mM CaCl2, 1 mM MgCl2, and 10
mM glucose. Depolarizing solution (identical except for NaCl (90 mM)
and KCl (60 mM)) was applied using a motor-driven two barrel Piezo
perfusion device (Warner Instruments, Hamden, CT), allowing for fast
(10-ms) switching between depolarizing and basal solution. Total
internal reflection fluorescence (TIRF) microscopy was performed on a
Zeiss inverted microscope with custom built TIRF set up (Till Photonics,
Grafelfing, Germany), using a 100 objective with 1.45 numerical
aperture. The depth of the evanescent field was measured to be 128 nm.
Images were collected at 30 Hz using an intensified CCD camera
(I-Pentamax; Roper Scientific) and analyzed with Metamorph (Univer-
sal Imaging Corp., Downingtown, PA). Fluorescence intensity was
measured in a region of interest over the cell and corrected for back-
ground measured outside of the cell.
Expression and Purification of GST-DOC2B—Full-length rat
DOC2B cDNA was cloned into the expression vector pGEX4T3 (Amer-
sham Biosciences) to encode a fusion protein of glutathione S-transfer-
ase (GST) and DOC2B. To isolate GST-DOC2B, 5 liters of Luria broth
medium with 100 g/ml ampicillin and 0.2% glucose was incubated at
37 °C until the exponential growth phase was reached. The incubation
was then prolonged for 4 h in the presence of 100 M isopropyl-1-thio-
-D-galactopyranoside to induce expression. Bacteria were centrifuged
for 15 min at 4,000  g and resuspended in 100 ml of HBS buffer (140
mM NaCl, 50 mM HEPES, pH 7.4, and protease inhibitor mixture; Roche
Applied Science catalog no. 1836170). The cells were lysed by sonication
and incubated for 1 h at 4 °C in the presence of 2.5% Triton X-100 for
solubilization. After clearing the lysate by centrifugation for 30 min at
15,000  g and 4 °C, GST-DOC2B was affinity-purified using glutathi-
one-conjugated Sepharose 4B beads (Sigma). The amount of bound
protein was determined by eluting GST-DOC2B in HBS plus 10 mM
glutathione from a sample of the beads, followed by a Bradford assay
using bovine serum albumin as a standard. The final yield of recombi-
nant protein was 1.2 mg/liter of culture volume.
Liposome Binding Assay—3H-Labeled liposomes were prepared by
drying a mixture of 125 l of phosphatidylcholine, 50 l of phosphati-
dylserine (both 10 mg/ml in chloroform; Sigma), and 20 l of 1,2-
dipalmitoyl, L-3-phosphatidyl [N-methyl-3H]choline (1 mCi/ml; specific
activity 83 Ci/mmol; Amersham Biosciences) under a nitrogen gas flow.
The phospholipids were suspended in 10 ml of 10 mM HEPES, pH 7.2,
and 100 mM NaCl, sonicated for 30 s, and centrifuged for 10 min at
3,000  g to remove aggregates from the liposome suspension. Buffered
Ca2 solutions were prepared in 50 mM HEPES, pH 7.20, 140 mM NaCl,
and 10 mM EGTA (1 M free Ca2) or HEDTA (1 M free Ca2) as a
chelator. The concentrations of total Ca2 were calculated with Win-
Maxc version 2.40 (Chris Patton, Stanford, CA; available on the World
Wide Web at www.standford.edu/cpatton). Liposome binding was as-
sayed in each buffer by incubating 50 l of a 25% Sepharose slurry
containing 50 g of immobilized GST-DOC2B with 100 l of the 3H-
labeled liposome suspension for 1 h at 20 °C in a total volume of 1.5 ml.
The beads were collected by centrifugation for 5 min at 1,000  g and
washed with 1.5 ml of the same buffered Ca2 solution. After five
washes, bound 3H-labeled phospholipids were eluted from the beads in
0.5% SDS, and radioactivity was quantitated by liquid scintillation
counting in UltimaGold mixture (Packard).
RESULTS
To investigate the possibility that DOC2B may function as a
Ca2 sensor in the activity-dependent enhancement of exocy-
tosis, we first used heterologous cell lines to analyze whether
Ca2 influences the cellular distribution of DOC2B. To focus
exclusively on Ca2-dependent mechanisms, we selected
HEK293 cells that lack endogenous expression of Munc13, thus
excluding the diacylglycerol-induced DOC2B translocation for
which Munc13 is required (11). Fusion proteins consisting of
full-length DOC2B and EGFP were expressed in HEK293 cells
as stable proteins with the expected molecular mass (Fig. 1).
The full-length band was also recognized by a polyclonal anti-
body against DOC2B, whereas this antibody did not recognize
EGFP alone (Fig. 1B). To investigate whether the EGFP tag
could cause mislocalization of the expressed protein, we com-
pared the cellular distribution of DOC2B-EGFP with that of
untagged DOC2B. As shown in Fig. 1, C and F, both proteins
produced a similar staining pattern using anti-DOC2B anti-
body. The immunostaining pattern was also similar to the
fluorescence derived directly from the EGFP tag, except that
the nuclear staining was relatively weak (Fig. 1, C–E). The
antigenic region could be less accessible in nuclear-resident
DOC2B-EGFP. As an additional control we replaced EGFP
with a Myc tag, resulting in the same distribution under all
conditions tested (data not shown). The distribution of DOC2B-
Myc was again similar to that of the untagged DOC2B vari-
ants. From these control experiments, we conclude that the
EGFP tag does not cause instability or artifacts in the subcel-
lular localization of DOC2B.
Ca2-dependent Localization of DOC2B-EGFP in Heterolo-
gous Cells—Under standard culture conditions, DOC2B-EGFP
and DOC2B were homogenously distributed in the cytoplasm
and nucleus of transfected HEK293 cells. The fluorescence
intensity in the nucleus varied between cells. The same homog-
enous distribution was observed when the cells were incubated
in basal buffer lacking Ca2. In contrast, when the cells were
incubated under conditions that elevate intracellular Ca2 lev-
els, DOC2B-EGFP showed a clearly distinct distribution char-
acterized by an intense membrane-associated fluorescence and
FIG. 1. A and B, DOC2B-EGFP is expressed in HEK293 cells as a
stable fusion protein of the expected molecular mass. HEK293 cells
were transfected with expression vectors encoding DOC2B-EGFP fu-
sions (lanes 1–3) or EGFP alone (lane 4). The cell lysates were analyzed
by Western blotting using anti-GFP (A) or anti-DOC2B antibodies (B).
We compared fusion proteins with wild type DOC2B (lane 1) with the
mutated variants M13 (lane 2) and TCT (lane 3). Please refer to Table
I for detailed information about these mutations. Right panel, the
EGFP tag does not influence the subcellular localization of DOC2B. A
HEK293 cell expressing DOC2B-EGFP was visualized by anti-DOC2B
immunostaining (C, red) or EGFP fluorescence (D, green). An overlay
of both images is shown in E. A similar distribution was also observed
by immunostaining cells that expressed untagged DOC2B (F, red).
Bar, 10 m.
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a loss of cytoplasmic fluorescence. This is shown in Fig. 2,
where Ca2 influx was induced by the extracellular application
of 3 mM Ca2 and a 1 M concentration of the Ca2 ionophore
A23187. Following this treatment, a redistribution of the fusion
protein was evident within less than 10 s. After stimulation,
the membrane-associated fluorescence was not completely uni-
form along the cell membrane but showed focal accumulations
(Fig. 2, arrowheads). The overall fluorescence intensity in the
cytoplasm, membrane, and nucleus was quantitated at differ-
ent time points in nine different cells. Cytoplasmic fluorescence
decreased significantly (p  0.005) to 44  3% of the original
value (mean  S.E., n 	 9), whereas the membrane-associated
fluorescence increased significantly (p  0.005) to 131  6%.
The nuclear fluorescence intensity remained constant (mean
value 101  1%). We therefore conclude that DOC2B-EGFP
migrates from the cytoplasm to the plasma membrane after
Ca2 influx.
To exclude a nonspecific activity of the ionophore A23187 or
its solvent, the ionophore was administered in the absence of
extracellular Ca2. This treatment did not induce any change
in fluorescence distribution (Fig. 3, C and G). When 3 mM
extracellular Ca2 was applied without the ionophore, there
was a small but detectable increase in plasma membrane-
associated fluorescence (Fig. 3, B and F). This subtle change
may reflect a small increase in intracellular Ca2 as a conse-
quence of the extracellular rise in Ca2 concentration. Only
after application of both components at the same time did a
quantitative translocation of the fluorescent protein occur (Fig.
3, D and H). We also investigated whether the translocation
was reversible and repeatable (Fig. 3, I–P). Cells expressing
DOC2B-EGFP were stimulated as described above. The me-
dium was then replaced to wash out the ionophore, resulting in
a reversal of the membrane-associated fluorescence to a homog-
enous cytoplasmic distribution. An additional replacement
with stimulation medium again induced a translocation of
DOC2B-EGFP to the plasma membrane. These control exper-
iments indicate that the observed translocation of DOC2B-
EGFP requires Ca2 influx and is not caused by irreversible
cell damage due to the stimulation treatment.
The Ca2-induced Translocation of DOC2B Is Independent of
Munc13 and Tctex-1 Binding—The binding of DOC2B to the
plasma membrane could be mediated by accessory proteins or
by direct binding of one of the C2 domains to the phospholipid
bilayer. To investigate the participation of each functional do-
main, we introduced targeted mutations in the N-terminal
domain to block the interaction with Munc13 and Tctex-1 (a
subunit of the cytoplasmic dynein complex), respectively (Fig.
4) (see Table I). All mutants expressed showed the expected
molecular mass without visible signs of degradation in Western
blotting (Fig. 1).
Although HEK293 cells do not express Munc13 to detectable
amounts as analyzed by immunoblotting, the above experi-
ments do not exclude the involvement of extremely low
amounts of Munc13. Therefore, we introduced a previously
characterized mutation in the Munc13-interacting domain of
DOC2B that abolishes Munc13 binding (12) (see Table I). To
confirm that this mutation blocks the Munc13-dependent
translocation triggered by phorbolesters, we first co-expressed
DOC2B-EGFP and Munc13-1 in HEK293 cells. In agreement
with previously reported studies (11), the administration of the
phorbolester phorbol 12-myristate 13-acetate resulted in a
translocation of DOC2B-EGFP (Fig. 5A). When the same treat-
FIG. 2. Subcellular localization of DOC2B-EGFP in response to
Ca2 influx. Upper panel, live confocal imaging of HEK293 cells ex-
pressing DOC2B-EGFP. Transfected cells were incubated under basal
conditions (t 	 0). Ca2 influx was induced by the addition of 1 M
A23187 and 3 mM CaCl2 to the extracellular medium. The time after
induction is indicated in seconds. Bar, 10 m. Lower left panel, time-
dependent change in fluorescence intensity in each cellular compart-
ment after induction of Ca2 influx. Values are expressed as percent-
ages of the original fluorescence. Lower right panel, relative
fluorescence in the nucleus (N), cytoplasm (C), and plasma membrane
(M), presented as mean values of measurements in nine different cells.
The bars indicate S.E.; asterisks indicate a significant change in fluo-
rescence intensity (p  0.005).
FIG. 3. Upper panel, both Ca2 and ionophore A23187 are required
for DOC2B-EGFP translocation. Live confocal imaging is shown of
HEK293 cells, incubated 48 h post-transfection at 37 °C in basal me-
dium without supplement (A and E) or supplemented with 3 mM CaCl2
(B and F), 1 M A23187 (C and G), or both (D and H). Lower panel, the
translocation of DOC2B-EGFP is both reversible and repeatable.
HEK293 cells expressing DOC2B-EGFP were stimulated by the admin-
istration of 3 mM Ca2 and 1 M A23187 (I). Subsequently, the medium
was replaced with basal buffer containing 3 mM EGTA, which resulted
in a reversal of the translocation (J–M). The medium was then replaced
with buffer containing 3 mM Ca2 and 1 M A23187 (N–P). Bars, 10 m.
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ment was performed with the mutated DOC2B-EGFP variant
(M13), no translocation was observed (Fig. 5B). However, when
the same cells were stimulated with 3 mM Ca2 and 1 M
ionophore, the mutated protein readily translocated to the
plasma membrane (Fig. 5C). Having confirmed that the M13
mutation effectively blocks the phorbolester-induced transloca-
tion of DOC2B-EGFP, we next expressed mutated DOC2B-
EGFP without co-expression of Munc13 (Fig. 6). Upon induc-
tion of Ca2 influx, the mutant fusion protein rapidly
associated with the plasma membrane in a way that was in-
distinguishable from wild type DOC2B-EGFP. From these
data, we conclude that Ca2-induced translocation of DOC2B is
not mediated by binding to Munc13.
Another mutation named TCT (20) (see Table I) was intro-
duced in the N-terminal domain to assess the role of Tctex-1
binding in the Ca2-induced translocation of DOC2B-EGFP.
Again, this mutation did not influence the basal localization or
translocation activity of the fusion protein (Fig. 4, TCT
 and
TCT), indicating that the interaction with the dynein-binding
motif at the N terminus of DOC2B is not involved.
Since the Ca2-induced recruitment of DOC2B-EGFP to the
plasma membrane binding is independent of Munc13 and Tx-
tex-1, the most likely explanation for this phenomenon is a
Ca2-triggered C2 domain activation. To test this hypothesis,
we expressed and purified our full-length DOC2B construct in
the form of a bacterial fusion protein with GST and analyzed
whether it could bind phospholipids in a Ca2-dependent man-
ner. The GST-DOC2B fusion protein (calculated molecular
mass, 72 kDa) appeared in SDS-PAGE as a predominant band
at the expected height (Fig. 7A). Several additional bands were
visible that corresponded with a lower molecular mass, indic-
ative of a limited amount of protein degradation (asterisk). The
GST-DOC2B protein alone was sufficient to bind liposomes in a
Ca2-dependent manner, showing a half-maximal binding ac-
tivity of 5 M free Ca2. This Ca2-dependent phospholipid
binding activity is comparable with that of an isolated C2A
FIG. 4. Ca2-dependent localization
of mutant DOC2B-EGFP variants.
HEK293 cells were transfected with full-
length DOC2B with EGFP attached to its
carboxyl terminus. Besides wild type
DOC2B (WT), we also analyzed the mu-
tants named TCT and M13 (see Table I)
and, as controls, EGFP alone (GFP),
PKC-, and PKC-. Prior to fixation, the
cells were incubated for 10 min under ba-
sal conditions (indicated by a minus sign)
or in the presence of 1 M A23187 and 3
mM Ca2 (indicated by a plus sign). Alter-
natively, the cells were stimulated by 10
mM Ba2 added to the basal medium (in-
set). Bars, 10 m.
FIG. 5. Mutagenesis at the Munc13-interacting domain blocks
phorbolester-induced membrane binding by DOC2B-EGFP.
HEK293 cells co-expressing Munc13.1 and DOC2B-EGFP were stimu-
lated by application of the phorbolester phorbol 12-myristate 13-acetate
to a final concentration of 100 nM, resulting in a translocation of the
fluorescent DOC2B-EGFP protein to the membrane (A) (the time after
induction is indicated in seconds). When wild type DOC2B was replaced
with its mutated variant M13 (see Table I), the same treatment did not
induce translocation (B). Stimulation of the same cell with 3 mM Ca2
and 1 M A23187, in contrast, readily induced a translocation of the
mutated DOC2B-EGFP protein (C). Bars, 5 m.
FIG. 6. Upper panel, live confocal imaging of the DOC2B-EGFP mu-
tant designated M13. The time after the addition of 3 mM Ca2 and 1 M
A23187 is indicated in seconds. The mutation is described in Table I.
Bar, 10 m. Lower left panel, time-dependent change in fluorescence
intensity in each cellular compartment. Values are expressed as per-
centages of the original fluorescence. Lower right panel, relative fluo-
rescence in the nucleus (N), cytoplasm (C), and cell membrane (M) after
the addition of 1 M A23187 and 3 mM CaCl2, presented as mean values
of five measurements in five different cells. The bars indicate S.E.; the
asterisk indicates a significant change in fluorescence intensity (p 
0.005).
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domain fragment as shown previously (8). These results indi-
cate that the Ca2-dependent plasma membrane association of
DOC2B is primarily mediated by the C2 domains.
Kinetic Properties of Ca2-induced Plasma Membrane Bind-
ing in PC12 Cells—The above results showed that DOC2B-
EGFP is recruited by Ca2 to the plasma membrane in heter-
ologous cells. We also used PC12 cells, derived from chromaffin
cells of the adrenal gland, to test whether a similar transloca-
tion occurred in cells that are specialized in Ca2-dependent
exocytosis. Transfected PC12 cells showed the same homoge-
nous distribution of DOC2B-EGFP under basal conditions and
the same translocation of the protein to the plasma membrane
after stimulation of Ca2 influx (analyzed by live confocal im-
aging; data not shown).
For an accurate kinetic analysis of the Ca2-induced plasma
membrane binding, we used the TIRF microscopy technique.
This technique specifically records fluorescence at the plasma
membrane with a high temporal resolution. A typical experi-
ment is depicted in Fig. 8. PC12 cells expressing DOC2B-EGFP
were analyzed during 30 s for their fluorescence intensity at
the membrane. After an initial incubation in basal solution, the
cells were depolarized for 10 s to induce Ca2 influx, followed
by a second incubation in basal solution. The membrane depo-
larization induced a marked increase in DOC2B-EGFP fluores-
cence, followed after removal of the stimulus by a complete
reversal to the original fluorescence intensity (Fig. 8). On av-
erage, among nine individual cells, the membrane-associated
fluorescence increased 3-fold. The rise and decay components of
the observed changes in membrane-associated fluorescence fol-
lowed different kinetic rates, which were optimally fitted by
monoexponential curves with half-time constants of 2.05 
0.11 and 7.9  0.6 s, respectively (mean  S.E., n 	 9). In
conclusion, the Ca2-induced membrane association of
DOC2B-EGFP is rapid and also occurs in PC12 cells that are
specialized in Ca2-triggered exocytosis.
Localization of DOC2B in Neurons—Since DOC2B is highly
expressed in neurons of the brain, we next asked whether the
Ca2-induced plasma membrane association also occurs in
neurons. Cultured mouse neurons were transduced with lenti-
viral expression vectors (21) encoding DOC2B-EGFP. The level
of DOC2B-EGFP expression could be detected 7 days after
transduction and was sustained to the maximum period ana-
lyzed (i.e. 8 weeks post-transduction), indicating that virus-
encoded DOC2B-EGFP expression does not compromise the
viability of neurons. The recombinant protein was found
throughout the neuron, including the soma and the neurite
extensions (Fig. 9A; a three-dimensional rendering of this im-
age is available as Supplemental Data). The fusion protein was
also present in local accumulations along the dendritic and
axonal extensions. Neuronal identity was confirmed by coun-
terstaining for the neuronal dendritic marker, MAP2 (Fig. 9,
B–H). Under normal culture conditions (i.e. at physiological
concentrations of intracellular Ca2), we observed a significant
cell-to-cell variation in the localization of DOC2B-EGFP. Typ-
ically, the fluorescence was found partly at the membrane and
in the cytoplasmic compartment (Fig. 9B). Interestingly,
DOC2B-EGFP also associated with intracellular membranes in
neurons. To investigate whether the partial membrane associ-
ation of DOC2B was due to the endogenous levels of intracel-
lular Ca2, we incubated the neurons in basal buffer lacking
Ca2. This treatment indeed resulted in a cytoplasmic distri-
bution of the fluorescent signal (Fig. 9C). Stimulation of neu-
rons by application of a depolarizing solution readily induced
plasma membrane association of DOC2B-EGFP within 10 s
(Fig. 9D) as expected. A similar translocation was induced by
treatment of the neurons with a Ca2 ionophore (data not
shown). The translocation of DOC2B-EGFP was reversible and
repeatable, as confirmed by live confocal imaging (Fig. 10).
Thus, our results indicate that the Ca2-induced plasma mem-
brane binding activity of DOC2B-EGFP is relevant in neurons
and that endogenous Ca2 concentrations in cultured neurons
are in the appropriate range to dynamically influence the mem-
brane binding activity of DOC2B.
We also tested the expression pattern in neurons of the
mutant DOC2B-EGFP variants designated M13 and TCT. The
results corresponded with those obtained in HEK293 cells. The
M13 mutant showed a cytoplasmic fluorescence pattern in ba-
sal buffer lacking Ca2 (Fig. 9E). After the stimulation of Ca2
influx, the fluorescence shifted to a membrane-associated pat-
tern (Fig. 9F). Under standard culture conditions, fluorescence
was observed both in the cytoplasmic compartment and at the
membrane (not shown). The same dynamic behavior was ob-
served for the mutant TCT (Fig. 8, G and H). Therefore, also in
neurons, the interactions of DOC2B with Munc13 and Tctex-1
are not required for its Ca2-induced recruitment.
DISCUSSION
In this study, we investigated the intracellular localization of
DOC2B, a high affinity Ca2 sensor with a putative function in
regulated exocytosis. We found that Ca2 influx is sufficient to
induce a rapid and complete translocation of cytosolic DOC2B-
EGFP to the target membrane in living cells. This activity was
observed in heterologous cells and PC12 cells (specialized in
FIG. 7. Ca2-dependent phospholipid binding by purified GST-
DOC2B. A, purification of a bacterial fusion protein composed of GST
and full-length DOC2B. GST (lane 1) and GST-DOC2B (lane 2) were
analyzed by SDS-PAGE and Coomassie Brilliant Blue staining. M,
marker lane. In addition to the full-length protein, several weak addi-
tional bands indicate a limited amount of protein degradation (asterisk).
Panel B, binding of 3H-labeled liposomes to immobilized GST-DOC2B
as a function of the free Ca2 concentration. Liposomes were prepared
from phosphatidylcholine and phosphatidylserine in a 5:2 (w/w) ratio.
The error bars indicate S.E. (n 	 3).
FIG. 8. Kinetics of Ca2-induced membrane association.
Plasma membrane-associated DOC2B-EGFP was analyzed in PC12
cells by TIRF microscopy. The trace shows an example recording of
fluorescence intensity during 30 s. The bar indicates potassium-induced
depolarization of the cell for 10 s. The inset shows averaged parameters
measured from nine individual transfected cells. F/F0 represents the
change in fluorescence intensity relative to the original value. on and
off represent the half-time constants (in seconds) of fitted monoexpo-
nential curves for membrane binding and release, respectively.
Ca2-induced Recruitment of DOC2B to the Target Membrane 23745
 at Vrije Universiteit, Medical Library, on December 21, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
Ca2-dependent large dense core vesicle exocytosis). Moreover,
the Ca2-induced translocation also occurred in neurons,
known to express endogenous DOC2B at high levels (7).
The presence of an EGFP tag at the C terminus of full-length
DOC2B did not influence its cellular localization. As shown by
Western blotting, the recombinant fusion proteins were soluble
and stable. Furthermore, the distribution of the fusion protein
was similar to untagged DOC2B. Polyclonal antibodies pro-
duced a similar staining pattern compared with the direct
fluorescence from DOC2B-EGFP, but the immunostaining was
relatively weak in the nuclear compartment. We speculate that
DOC2B-EGFP in the nucleus represents an incorrectly folded
subpopulation of the overexpressed recombinant protein that is
not recognized by the antibody. DOC2B contains several basic
amino acid clusters that are normally buried in the C2 domain
structure and could aberrantly act as a nuclear localization
signal in misfolded protein. Therefore, the observed cell-to-cell
variation in nuclear fluorescence may correspond with varia-
tions in the cellular expression level and hence with the accu-
racy of protein folding.
The Ca2-induced mobilization of DOC2B represents a novel
mechanism, distinct from the previously described Munc13-de-
pendent translocation in response to diacylglycerol synthesis
(11). This conclusion is based on the following considerations.
First, DOC2B-EGFP translocated in HEK293 cells that do not
express Munc13. Second, mutation of the Munc13-interacting
domain of DOC2B did not inhibit Ca2-induced membrane
binding, but it completely blocked the phorbolester-induced
translocation. This mutation was previously demonstrated to
block Munc13-binding activity of this domain in a cell-free
system (12). In this study, we provide a further characteriza-
tion of the same mutation and conclude that it does not disrupt
DOC2B stability, basal localization, and Ca2-induced mem-
brane binding. The selective inhibition of diacylglycerol-in-
duced Munc13 binding in this mutant, however, makes this
mutant protein a valuable tool to dissect the phorbolester- and
Ca2-dependent activation pathways in future research. Taken
together, our data fully support the previously identified trans-
location in response to phorbolester stimulation, a phenomenon
that requires the presence of Munc13. In addition, we have
demonstrated that Ca2 elevations alone also recruit DOC2B
to the plasma membrane, and both mechanisms are truly in-
dependent. In Munc13-expressing cells, both mechanisms
probably converge to achieve a synergistic activation of DOC2B
by Ca2 influx and diacylglycerol synthesis near active exocy-
totic sites.
The Ca2-induced recruitment most likely involves a direct
interaction of its C2 domains with the phospholipid layer of the
target membrane. In a cell-free assay, purified DOC2B (ex-
pressed as a bacterial fusion protein with GST) bound to syn-
FIG. 9. Expression of DOC2B-EGFP fusion protein in cultured
mouse hippocampal neurons. A, vertical projection of multiple con-
focal planes showing that DOC2B-EGFP was expressed in the neuronal
soma and throughout the neurite extensions. B–H, confocal images of
neurons expressing DOC2B-EGFP (green) counterstained for the neu-
ronal dendritic marker MAP2 (red) to confirm the neuronal identity.
Besides the wild type form of DOC2B (B–D), the neurons expressed
fusion proteins containing mutated variants designated M13 (E and F)
and TCT (G and H). The neurons were incubated in basal buffer lacking
Ca2 (A, C, E, and G), normal culture medium (B), or depolarizing
buffer containing 60 mM KCl (D, F, and H). Bars, 10 M. A Quicktime
movie showing a three-dimensional rendering of the neuron shown in A
is available as Supplemental Data.
FIG. 10. Live confocal imaging analysis of three neurons ex-
pressing DOC2B-EGFP. A–H, a neuron expressing DOC2B-EGFP
was incubated subsequently in basal buffer containing 3 mM EGTA (A),
in depolarizing buffer containing 60 mM KCl (B–D), in basal buffer
again (E–G), and in depolarizing buffer again (H). The incubation times
were 1, 5, and 30 s in depolarizing buffer (B–D); 5, 10, and 30 s in
EGTA-containing buffer (E–G); and 1 s in depolarizing buffer (H),
respectively. Bars, 50 M. Panels I and J and panels K and L show a
similar potassium-induced translocation in two other neurons. Quick-
time movies corresponding to panels I and J and panels K and L are
available as Supplemental Data.
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thetic liposomes containing phosphatidylcholine and phos-
phatidylserine in a Ca2-dependent way. Our results are in
accordance with a previous study that showed liposome binding
by a DOC2B fragment containing only the C2A domain, show-
ing a similar dependence on the free Ca2 concentration (8). By
contrast, the isolated C2B domain did not show Ca2-induced
phopholipid affinity in vitro (8). Therefore, the most simple
explanation for the Ca2-induced translocation of DOC2B is
that Ca2 causes a conformational or electrostatic change
through binding to the C2A domain, resulting in an increased
affinity of DOC2B for phospholipids of the plasma membrane.
Similar Ca2-dependent phospholipid-C2 domain interactions
were observed previously in several other proteins (e.g. synap-
totagmins and PKC isoforms) (see Ref. 22). As prototype C2
proteins with a Ca2-dependent plasma membrane binding
activity (18, 19), we also tested the localization of PKC and -
in our assay. Remarkably, under the conditions used (1 M
ionophore), the DOC2B-EGFP translocation was clearly more
pronounced than that of the PKC isoforms, which require more
stringent concentrations for their activation (e.g. 10–80 M
ionophore), suggesting that DOC2B is activated by relatively
low concentrations of intracellular Ca2.
Several lines of evidence have indicated a regulatory role of
DOC2 proteins in Ca2-induced exocytosis, located upstream
from the actual fusion event (9, 12, 13, 23–25). This is also
suggested by the interaction of DOC2 with Munc18 and
Munc13, both essential components of the vesicle docking/
priming machinery (3, 14). Our results are fully consistent with
a putative function in activity-dependent enhancement of exo-
cytosis, considering that 1) the speed of translocation is suffi-
ciently high and 2) the translocation occurs at intracellular
Ca2 levels within the dynamic physiological range. With re-
spect to the speed of translocation, we observed in our experi-
ments in PC12 cells that DOC2B-EGFP bound to the mem-
brane with a monoexponential half-time of 2.05 s. Of the
distinct components involved in activity-dependent enhance-
ment, this kinetic rate corresponds best with the relatively
slow components defined as augmentation (1 s) and potenti-
ation (10 s) (1). These components are thought to be activated
by residual Ca2 concentrations at locations distant from the
Ca2 channels. The translocation speed in response to Ca2 is
also comparable with the time scale of diacylglycerol-mediated
potentiation, known to require Munc13 (26) and its interaction
with DOC2 (12, 13). The diacylglycerol/Munc13-induced trans-
location of DOC2B to the plasma membrane, on the other hand,
has been observed in the range of 5–30 min previously (11) and
after 30–50 s in our experiments. Thus, the kinetic parameters
from our studies are consistent with a proposed function in
activity-dependent enhancement of exocytosis.
A putative role in activity-dependent enhancement of exocy-
tosis is furthermore supported by the apparent Ca2 sensitivity
of DOC2B. Estimated concentrations of intracellular Ca2 in
neurons range from 10–100 M during Ca2 channel opening to
1 M during delayed phases after Ca2 influx and 100 nm
under resting conditions (2, 27). The peak levels are only
reached transiently (for milliseconds) in close proximity to ac-
tivated Ca2 channels. For DOC2B, half-maximal phospholipid
binding by the isolated C2A domain occurs at a concentration of
1 M (8). We show here that in cultured neurons expressing
full-length DOC2B, a partial membrane association occurs al-
ready at physiological Ca2 concentrations. Depletion of Ca2
from the medium reversed this membrane association. Hence,
the observed variability between individual cells was probably
caused by differences in intracellular Ca2 levels. This impli-
cates that DOC2B translocation occurs in living cells that have
accumulated relatively high intracellular Ca2 concentrations
as a result of their physiological activity, further supporting a
function in activity-dependent enhancement of exocytosis.
Combining the available data, we propose that DOC2B cou-
ples intracellular Ca2 elevations to the activity-dependent
enhancement of exocytosis by the following mechanism. During
the temporary rise in intracellular Ca2 after exocytotic activ-
ity, DOC2B rapidly associates with the target membrane. In-
dependently, DOC2B may engage into a membrane-bound com-
plex with Munc13 in response to local diacylglycerol production
(10, 11). Through one or more downstream interactions that
remain to be elucidated, this DOC2B-Munc13 interaction fi-
nally results in the activity-dependent enhancement of exocy-
totic strength.
Acknowledgments—We thank Alexey Kochubey for invaluable ad-
vice on TIRF microscopy, Martin Rook for assistance in live confocal
imaging techniques, and Klaas-Jan de Vries for the preparation of a
DOC2B antigen. We are also grateful to Prof. Nils Brose,
Prof. Dominique Joubert, and Prof. Naoaki Saito for providing ex-
pression vectors encoding Munc13-1, PKC-, and PKC-,
respectively.
REFERENCES
1. Fisher, S. A., Fischer, T. M., and Carew, T. J. (1997) Trends Neurosci. 20,
170–177
2. Zucker, R. S., and Regehr, W. G. (2002) Annu. Rev. Physiol. 64, 355–405
3. Augustin, I., Rosenmund, C., Sudhof, T. C., and Brose, N. (1999) Nature 400,
457–461
4. Rhee, J. S., Betz, A., Pyott, S., Reim, K., Varoqueaux, F., Augustin, I., Hesse,
D., Sudhof, T. C., Takahashi, M., Rosenmund, C., and Brose, N. (2002) Cell
108, 121–133
5. Fukuda, M., and Mikoshiba, K. (2000) Biochem. Biophys. Res. Commun. 276,
626–632
6. Sakaguchi, G., Orita, S., Maeda, M., Igarashi, H., and Takai, Y. (1995) Bio-
chem. Biophys. Res. Commun. 217, 1053–1061
7. Verhage, M., de Vries, K. J., Roshol, H., Burbach, J. P., Gispen, W. H., and
Sudhof, T. C. (1997) Neuron 18, 453–461
8. Kojima, T., Fukuda, M., Aruga, J., and Mikoshiba, K. (1996) J. Biochem.
(Tokyo) 120, 671–676
9. Orita, S., Sasaki, T., Komuro, R., Sakaguchi, G., Maeda, M., Igarashi, H., and
Takai, Y. (1996) J. Biol. Chem. 271, 7257–7260
10. Orita, S., Naito, A., Sakaguchi, G., Maeda, M., Igarashi, H., Sasaki, T., and
Takai, Y. (1997) J. Biol. Chem. 272, 16081–16084
11. Duncan, R. R., Betz, A., Shipston, M. J., Brose, N., and Chow, R. H. (1999)
J. Biol. Chem. 274, 27347–27350
12. Mochida, S., Orita, S., Sakaguchi, G., Sasaki, T., and Takai, Y. (1998) Proc.
Natl. Acad. Sci. U. S. A. 95, 11418–11422
13. Hori, T., Takai, Y., and Takahashi, T. (1999) J. Neurosci. 19, 7262–7267
14. Verhage, M., Maia, A. S., Plomp, J. J., Brussaard, A. B., Heeroma, J. H.,
Vermeer, H., Toonen, R. F., Hammer, R. E., van den Berg, T. K., Missler,
M., Geuze, H. J., and Sudhof, T. C. (2000) Science 287, 864–869
15. Voets, T., Toonen, R. F., Brian, E. C., de Wit, H., Moser, T., Rettig, J., Sudhof,
T. C., Neher, E., and Verhage, M. (2001) Neuron 31, 581–591
16. Toonen, R. F., and Verhage, M. (2003) Trends Cell Biol. 13, 177–186
17. Brose, N., Hofmann, K., Hata, Y., and Sudhof, T. C. (1995) J. Biol. Chem. 270,
25273–25280
18. Vallentin, A., Prevostel, C., Fauquier, T., Bonnefont, X., and Joubert, D. (2000)
J. Biol. Chem. 275, 6014–6021
19. Sakai, N., Sasaki, K., Ikegaki, N., Shirai, Y., Ono, Y., and Saito, N. (1997)
J. Cell Biol. 139, 1465–1476
20. Nagano, F., Orita, S., Sasaki, T., Naito, A., Sakaguchi, G., Maeda, M., Wa-
tanabe, T., Kominami, E., Uchiyama, Y., and Takai, Y. (1998) J. Biol. Chem.
273, 30065–30068
21. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma,
I. M., and Trono, D. (1996) Science 272, 263–267
22. Rizo, J., and Sudhof, T. C. (1998) J. Biol. Chem. 273, 15879–15882
23. Duncan, R. R., Shipston, M. J., and Chow, R. H. (2000) Biochimie (Paris) 82,
421–426
24. Orita, S., Sasaki, T., and Takai, Y. (2001) Methods Enzymol. 329, 83–90
25. Sakaguchi, G., Manabe, T., Kobayashi, K., Orita, S., Sasaki, T., Naito, A.,
Maeda, M., Igarashi, H., Katsuura, G., Nishioka, H., Mizoguchi, A., Itohara,
S., Takahashi, T., and Takai, Y. (1999) Eur. J. Neurosci. 11, 4262–4268
26. Brose, N., and Rosenmund, C. (2002) J. Cell Sci. 115, 4399–4411
27. Bollmann, J. H., Sakmann, B., and Borst, J. G. (2000) Science 289, 953–957
Ca2-induced Recruitment of DOC2B to the Target Membrane 23747
 at Vrije Universiteit, Medical Library, on December 21, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
